Clasificación en acciones
#33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Precio por acción
$0.5099
Última sincronización: 2024-10-15
Capitalización bursátil
$7.60M
Comercio Anew Medical, Inc. (WENA)
Precio WENA con Capital del mercado a B
Capitalización de mercado de Anew Medical, Inc.(WENA)
Capitalización bursátil: $7.60M
A fecha de August 2026, Anew Medical, Inc. tiene una capitalización de mercado de $7.60M. Esto convierte a Anew Medical, Inc. en la 33455th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Anew Medical, Inc. desde 2024 hasta 2026
WENA en comparación con los más populares 5 títulos stocks
| Precio por WENA |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.452T
|
+71,731,742.10%
|
|
|
|
|
$4.490T
|
+59,076,428.18%
|
|
|
|
|
$4.162T
|
+54,765,924.71%
|
|
|
|
|
$3.676T
|
+48,370,628.76%
|
|
|
|
|
$2.833T
|
+37,275,082.79%
|
